Andrew J Piper-Vallillo (Andrew J Piper-Valillo, Andrew J Piper, Andrew J Piper Vallillo)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

PloS one

Clinical cancer research : an official journal of the American Association for Cancer Research

medRxiv : the preprint server for health sciences

BIDMC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BIDMC Jul 01 2018

United States

Clinical Fellow :: Hematology/Oncology

Publications

Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, Paul Stockhammer, Iris K van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J Piper-Vallillo, Zofia Piotrowska, Christina J Falcon, Helena Alexandra Yu, Charu Aggarwal, Dylan G Scholes, Tejas Patil, Christina Nguyen, Manali Phadke, Fang-Yong Li, Joel W Neal, Mark A Lemmon, Zenta Walther, Katerina Politi, Sarah B Goldberg
Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, Jonathan Wischhusen, Jaymin M Patel, Daniel B Costa, Mary Linton B Peters
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. medRxiv : the preprint server for health sciences (2020)
Andrew J Piper-Vallillo, Jennifer L Clark, Jose Mercado-Matos, Asia N Matthew-Onabanjo, Chung-Cheng Hsieh, Ali Akalin, Leslie M Shaw
Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC). PloS one 14 (8) (2019)

Andrew J Piper-Vallillo.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew J Piper-Valillo, Andrew J Piper, Andrew J Piper Vallillo)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew J Piper-Vallillo (Andrew J Piper-Valillo, Andrew J Piper, Andrew J Piper Vallillo)